Dyne Share Price

Dyne Share Price

NASDAQ: DYN | Mid Cap | Healthcare
$16.03
+$0.16 (0.98%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Dyne Stock Performance

Open
$16.07
Prev. Close
$15.88
Circuit Range
N/A
Day Range
$15.92 - $16.84
Year Range
$14.12 - $27.22
Volume
1,83,359
Average Traded
$16.26

Dyne Share Price Today

As of 20 November 2026, Dyne Therapeutics, Inc.'s share price is $16.03. The stock opened at $16.07, compared to its previous close of $15.88. During today's trading session, Dyne Therapeutics, Inc.'s share price traded between $15.92 and $16.84, with an average price of $16.38. Over the past 52 weeks, the stock has recorded a high of $27.22 and a low of $14.12. In terms of performance, Dyne Therapeutics, Inc.'s share price has declined by 17.07% over the last six months and is down 26.87% on a year-on-year basis.

Dyne Share Price Chart

Line chart of the Dyne price trend over the selected period. The price rose overall, ranging from 15.88 to 16.53, ending at 15.89.
$15.92$16.84
L
Show Current Price
H

Dyne Stock Fundamentals & Key Indicators

Market Cap
$2.06B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.23
Revenue (TTM)
$0.00
Return On Equity (TTM)
-64.98%
Profit Margin
N/A
Debt to Equity
0.24
Quarterly Earnings Growth YoY
-72.87%

Dyne Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$111.96-$120.85-$178.56-$193.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-7.94%-47.75%-8.39%

Dyne Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$168.10-$235.94-$317.42-$446.21
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-40.36%-34.53%-40.57%

Dyne Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets60.3731.9635.7140.73
Current Assets1126.59659.28129.38265.59
Total Assets1186.96691.23165.08306.33
Non Current Liabilities164.219.1422.725.87
Current Liabilities50.6342.2651.128.09
Total Liabilities214.8361.473.7953.96
Shareholders' Equity972.13629.8491.29252.36

Dyne Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-403.21-292.37-188.16-153.65
Investing-28.75-204.0883.3187.2
Financing890.31809.954.3237.39

About Dyne

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Dyne Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$16.87
$15.98
-4.20%
Oct 2026
$15.90
$16.68
+3.38%
Sep 2026
$25.18
$16.14
-38.16%
Aug 2026
$24.59
$26.09
+3.63%
Jul 2026
$22.37
$25.18
+13.35%
Jun 2026
$18.80
$22.21
+14.90%
May 2026
$17.38
$19.33
+10.14%
Apr 2026
$18.76
$17.55
-3.15%
Mar 2026
$14.77
$18.12
+15.93%
Feb 2026
$17.93
$15.63
-12.73%
Jan 2026
$19.59
$17.91
-8.41%
Dec 2025
$21.38
$19.55
-10.79%

Dyne Share Price FAQs